VirnetX Holding Corp VHC Capitalized Direct And Indirect Research And Development Costs

Capitalized Direct And Indirect Research And Development Costs at other companies

ESABESAB

$22.04M+7.2%

IBT

IbottaIBTA

$22.65M-42.0%

Mineralys Therapeutics, Inc.MLYS

$39.94M-11.2%

Opko HealthOPK

$195M0.0%

BTCSBTCS

$122.52K-26.2%

Shattuck Labs, Inc.STTK

$29.42M-8.4%

Other financials

Income statement

See full

Revenue-—

Operating income-$4.5M-11.4%

Net income-$4.4M-18.3%

EPS (diluted)-$1.16-14.9%

Balance sheet

See full

Cash & equivalents$14.8M-36.4%

Total debt$7.2M-10.8%

Total equity$18.9M-48.2%

Total assets$26.7M-40.8%

Cash flow

See full

Operating cash flow-$4.3M-10.3%

CapEx$17.0K—

Free cash flow-$5.8M-5.2%

Valuation

See full

Market cap$53.16M+26.6%

Enterprise value$45.6M+39.7%

P/S328.2×-512×

Profitability

See full

Operating margin-12,284.6%-6,084pp

Net margin-11,666.7%-5,775pp

FCF margin-35,193.8%—

Returns & leverage

See full

Return on equity-68.5%+181pp

Debt / equity0.4×+0.2×

Current ratio8.5×-9.2×

Where this comes from

Reported directly by VirnetX Holding Corp in its filing.

Tagged under the XBRL concept vhc:CapitalizedDirectAndIndirectResearchAndDevelopmentCosts.

The official record: VirnetX Holding Corp ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about VirnetX Holding Corp 's capitalized direct and indirect research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is VirnetX Holding Corp 's capitalized direct and indirect research and development costs?: VirnetX Holding Corp (VHC) reported capitalized direct and indirect research and development costs of $0 in Q4 2025.
What does capitalized direct and indirect research and development costs mean?: The net book value of research and development costs that have been capitalized as assets rather than expensed as incurred. This reflects the portion of R&D investment expected to provide future economic benefits through patented technology or software development. It is a critical indicator of the company's investment in long-term intellectual property and product development.